0000950170-23-057643.txt : 20231101
0000950170-23-057643.hdr.sgml : 20231101
20231101182408
ACCESSION NUMBER: 0000950170-23-057643
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231030
FILED AS OF DATE: 20231101
DATE AS OF CHANGE: 20231101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Feder Julie B
CENTRAL INDEX KEY: 0001710237
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40971
FILM NUMBER: 231369469
MAIL ADDRESS:
STREET 1: C/O VERASTEM, INC.
STREET 2: 117 KENDRICK STREET, SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aura Biosciences, Inc.
CENTRAL INDEX KEY: 0001501796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 320271970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 01235
BUSINESS PHONE: (617)500-8864
MAIL ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 01235
4
1
ownership.xml
4
X0508
4
2023-10-30
0001501796
Aura Biosciences, Inc.
AURA
0001710237
Feder Julie B
C/O AURA BIOSCIENCES, INC.
80 GUEST STREET
BOSTON
MA
01235
false
true
false
false
Chief Financial Officer
false
Common Stock
2023-10-30
4
S
false
3385
6.8215
D
69600
D
The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.80 to $7.1822, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Julie Feder
2023-11-01